Current price is less than the intrinsic value

Intrinsic value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry point

Red Flags Found

ANG Lifesciences India Ltd. is a small-cap pharmaceutical company with a market worth of Rs. 184.99 crore.

Multibagger pharma stock announces record date for bonus issue

ANG Lifesciences India fixes record date for bonus issue of 1:4

Multibagger stock: ANG Lifesciences India Ltd has informed Indian bourses that its board of directors has recommended issuance of bonus shares in 1:4 ratio

Multibagger stock to consider 1:4 bonus share issue. Details here

Brightcom Group Ltd, Megastar Foods Ltd, ANG Lifesciences India Ltd and Jindal Poly Investment & Finance Company Ltd are among the other losers in the BSE’s ‘B’ group today, 09 March 2022.

Universus Photo Imagings Ltd leads losers in ‘B’ group

DCM Ltd, Brightcom Group Ltd, ANG Lifesciences India Ltd and Arihant Superstructures Ltd are among the other losers in the BSE’s ‘B’ group today, 08 March 2022.

Patel Integrated Logistics Ltd Partly Paidup leads losers in ‘B’ group

Coastal Corporation Ltd, Weizmann Ltd, Ashapuri Gold Ornament Ltd and ANG Lifesciences India Ltd are among the other losers in the BSE’s ‘B’ group today, 16 February 2022.

Arrow Greentech Ltd leads losers in ‘B’ group

GRP Ltd, Allied Digital Services Ltd, ANG Lifesciences India Ltd and Anand Rayons Ltd are among the other losers in the BSE’s ‘B’ group today, 02 February 2022.

Vishwaraj Sugar Industries Ltd leads losers in ‘B’ group

ANG Lifesciences India hit an upper circuit limit of 5% at Rs 521.65 after the company said it will invest in the equity shares of ANG Healthcare India.

ANG Lifesciences spurts after acquisition

Board of ANG Lifesciences approves acquisition of ANG Healthcare India

The acquisition will help company in its brand-building, domestic branding and direct marketing initiative for the purposes of staying close to the customer.

ANG Lifesciences soars 5% after board announces plan to invest in ANG Healthcare India

Ambition Mica Ltd, Supreme Infrastructure India Ltd, Aditya Vision Ltd and ANG Lifesciences India Ltd are among the other losers in the BSE’s ‘B’ group today, 23 November 2021.

Starlineps Enterprises Ltd leads losers in ‘B’ group

ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials

ANG Lifesciences India Ltd

ANG Lifesciences India Ltd

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Multibagger pharma stock announces record date for bonus issue

ANG Lifesciences India fixes record date for bonus issue of 1:4

Multibagger stock to consider 1:4 bonus share issue. Details here

Universus Photo Imagings Ltd leads losers in ‘B’ group

Patel Integrated Logistics Ltd Partly Paidup leads losers in ‘B’ group

Arrow Greentech Ltd leads losers in ‘B’ group

Vishwaraj Sugar Industries Ltd leads losers in ‘B’ group

ANG Lifesciences India Ltd

Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Multibagger pharma stock announces record date for bonus issue

ANG Lifesciences India fixes record date for bonus issue of 1:4

Multibagger stock to consider 1:4 bonus share issue. Details here

Universus Photo Imagings Ltd leads losers in ‘B’ group

Patel Integrated Logistics Ltd Partly Paidup leads losers in ‘B’ group

Arrow Greentech Ltd leads losers in ‘B’ group

Vishwaraj Sugar Industries Ltd leads losers in ‘B’ group

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock